Register

Support: 888-992-3836|NewsWire|Home|Login / Register

Home > Boards > US Listed > Biotechs > Agile Therapeutics, Inc. (AGRX)

Good spread for the day and a lot

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Elpapibh

Followed By	2
Posts	547
Boards Moderated	0
Alias Born	03/22/19

160x600 placeholder

Current Report Filing (8-k) Edgar (US Regulatory) - 1/14/2021 8:31:36 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 6:31:27 AM

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference GlobeNewswire Inc. - 1/4/2021 12:18:15 PM

Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 12/21/2020 7:30:00 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2020 4:31:05 PM

Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol)... GlobeNewswire Inc. - 12/7/2020 7:30:00 AM

Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethin... GlobeNewswire Inc. - 11/30/2020 9:11:25 AM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2020 5:01:26 PM

Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 11/23/2020 4:46:36 PM

Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference GlobeNewswire Inc. - 11/23/2020 10:00:00 AM

Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2020 4:17:20 PM

Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2020 4:11:23 PM

Agile Therapeutics Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/12/2020 4:05:00 PM

Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial... GlobeNewswire Inc. - 11/4/2020 7:30:00 AM

Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/15/2020 6:30:17 AM

Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 10/2/2020 4:32:08 PM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 10/1/2020 4:26:17 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2020 4:11:13 PM

Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire Inc. - 9/22/2020 11:40:25 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2020 4:10:58 PM

Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference GlobeNewswire Inc. - 9/9/2020 8:00:10 AM

Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020 GlobeNewswire Inc. - 9/8/2020 8:00:10 AM

Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control GlobeNewswire Inc. - 9/2/2020 9:00:10 AM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/26/2020 5:00:53 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2020 4:16:35 PM

Elpapibh	Monday, 05/11/20 06:15:22 PM
Re: None
Post # of 1056

Good spread for the day and a lot of strong supports. We’ll see what’s going on

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Follow Board

Keyboard Shortcuts

Report TOS Violation

X


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist

Consent Preferences